Plasma GFAP levels were significantly higher in patients with PD at baseline (mean [SD]: 69.80 [36.18], pg/mL) compared to HCs (mean [SD]: 57.89 [23.54], pg/mL; Fig. 1A and Additional file 1: Table S1). This evidence concerns the gene GFAP and Parkinson disease.